Nutritional Challenges in Metabolic Syndrome
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Metabolic Syndrome (MetS) is a combination of risk factors for the development of cardiovascular disease (CVD) and type 2 diabetes. Different diagnostic criteria were proposed, but a consensus was reached in 2009 based on values of waist circumference, blood pressure, fasting glycemia, triglycerides, and high-density lipoprotein (HDL)-cholesterol levels. The main underlying etiologic factor is insulin resistance. The quality and quantity of individual macronutrients have an influence on the development and resolution of this syndrome. However, the main treatment goal is weight loss and a decrease in insulin resistance. A controlled energy dietary recommendation, together with moderate levels of physical activity, may positively change the parameters of MetS. However, there is no single dietary or exercise prescription that works for all patients. Dietary patterns such as Mediterranean-style, dietary approaches to stop hypertension (DASH), low-carbohydrate, and low-fat diets can ameliorate insulin resistance and MetS. Long-term adherence to a healthy lifestyle is key in assuring that individuals significantly reduce the risk of CVD and diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trumbo, P., Schlicker, S., Yates, A. A., & Poos, M. (2002) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(02)90346-9 · Cited by 5,993
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Sutton, E. F., Beyl, R., Early, K. S., Cefalu, W. T., Ravussin, E., & Peterson, C. M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.010 · Cited by 1,531
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496 · cited 2×
“However, they recognize that there is no definitive evidence for recommending an ideal amount of protein in relation either to glycemic control or for improving CVD risk factors [49].”
BackgroundA Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
Samaha, F. F., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, T., Williams, M., Gracely, E. J., & Stern, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022637 · Cited by 1,267 · cited 1×
“However, several landmark studies showed greater weight loss during the first six months of follow-up compared to conventional low-fat hypocaloric diets [27,28].”
BackgroundLiu, S., Willett, W. C., Stampfer, M. J., Hu, F. B., Franz, M., Sampson, L., Hennekens, C. H., & Manson, J. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1455 · Cited by 1,166 · cited 1×
“The GL concept allows comparison of blood glucose response to different types and amounts of foods [13,14].”
BackgroundNutrition therapy recommendations for the management of adults with diabetes
Evert, A. B., Boucher, J. L., Cypress, M., Dunbar, S. A., Franz, M. J., Mayer-Davis, E. J., Neumiller, J. J., Nwankwo, R., Verdi, C. L., Urbanski, P., et al. (2013) · Diabetes Care · doi:10.2337/dc13-2042 · Cited by 1,129 · cited 1×
“Nevertheless, since the ADA 2014 position statement, there is no “first-line” approach with respect to the optimal carbohydrate quantity in the diet plan, because evidence remains inconclusive [45].”
Vessby, B., Uusitupa, M., Hermansen, K., Riccardi, G., Rivellese, A. A., Tapsell, L. C., Nälsén, C., Berglund, L., Louheranta, A., Rasmussen, B. M., et al. (2001) · Diabetologia · doi:10.1007/s001250051620 · Cited by 1,119
Low–Glycemic Index Diets in the Management of Diabetes
Brand-Miller, J., Hayne, S., Petocz, P., & Colagiuri, S. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2261 · Cited by 951
Stern, L., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, M., Gracely, E. J., & Samaha, F. F. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-10-200405180-00007 · Cited by 831 · cited 1×
“However, several landmark studies showed greater weight loss during the first six months of follow-up compared to conventional low-fat hypocaloric diets [27,28].”
BackgroundObarzanek, E., Sacks, F. M., Vollmer, W. M., Bray, G. A., Miller, E. R., Lin, P.-H., Karanja, N. M., Most-Windhauser, M. M., Moore, T. J., Swain, J. F., et al. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.1.80 · Cited by 598
Järvi, A. E., Karlström, B. E., Granfeldt, Y. E., Björck, I. E., Asp, N. G., & Vessby, B. O. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.10 · Cited by 484 · cited 2×
“Along with these effects on insulin, diets enriched with MUFAs improve the lipid profile, because they reduce LDL-cholesterol and triglycerides, and elevate HDL-cholesterol levels [36–38].”
BackgroundSummers, L. K. M., Fielding, B. A., Bradshaw, H. A., Ilic, V., Beysen, C., Clark, M. L., Moore, N. R., & Frayn, K. N. (2002) · Diabetologia · doi:10.1007/s00125-001-0768-3 · Cited by 414
Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes
Wheeler, M. L., Dunbar, S. A., Jaacks, L. M., Karmally, W., Mayer-Davis, E. J., Wylie-Rosett, J., & Yancy, W. S. (2012) · Diabetes Care · doi:10.2337/dc11-2216 · Cited by 357
McMillan-Price, J., Petocz, P., Atkinson, F., O’Neill, K., Samman, S., Steinbeck, K., Caterson, I., & Brand-Miller, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.14.1466 · Cited by 335
Sugars, hypertriglyceridemia, and cardiovascular disease
Fried, S. K., & Rao, S. P. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.873s · Cited by 232
Saslow, L. R., Kim, S., Daubenmier, J. J., Moskowitz, J. T., Phinney, S. D., Goldman, V., Murphy, E. J., Cox, R. M., Moran, P., & Hecht, F. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091027 · Cited by 221 · cited 1×
“In those cases of high HbA1c, there is a greater reduction in HbA1c levels after carbohydrate restriction rather than after protein or lipid restriction [29].”
BackgroundTay, J., Thompson, C. H., Luscombe‐Marsh, N. D., Wycherley, T. P., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13164 · Cited by 215
Viguiliouk, E., Kendall, C. W., Kahleová, H., Rahelić, D., Salas-Salvadó, J., Choo, V. L., Mejia, S. B., Stewart, S. E., Leiter, L. A., Jenkins, D. J., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.032 · Cited by 201
Rivellese, A. A., Maffettone, A., Vessby, B., Uusitupa, M., Hermansen, K., Berglund, L., Louheranta, A., Meyer, B. J., & Riccardi, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00424-0 · Cited by 198
Should we recommend low‐fat diets for obesity?
Pirozzo, S., Summerbell, C., Cameron, C., & Glasziou, P. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00099.x · Cited by 117
Stentz, F. B., Brewer, A., Wan, J., Garber, C., Daniels, B., Sands, C., & Kitabchi, A. E. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000258 · Cited by 72
Patterson, S., Flatt, P. R., Brennan, L., Newsholme, P., & McClenaghan, N. H. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06537 · Cited by 63 · cited 1×
“In contrast, homocysteine can inhibit it [50,51].”
Cited by
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441
Metabolic Syndrome Pathophysiology and Predisposing Factors
Bovolini, A., Garcia, J., Andrade, M. A., & Duarte, J. A. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1263-0898 · Cited by 385
Fitzgerald, K. N., Hodges, R., Hanes, D., Stack, E., Cheishvili, D., Szyf, M., Henkel, J., Twedt, M. W., Giannopoulou, D., Herdell, J., et al. (2021) · Aging · doi:10.18632/aging.202913 · Cited by 361
“The reduction in serum triglycerides might be expected with a diet that lowered carbohydrate intake and glycemic response, plus exercise [32].”
BackgroundBakaloudi, D. R., Chrysoula, L., Kotzakioulafi, E., Theodoridis, X., & Chourdakis, M. (2021) · Nutrients · doi:10.3390/nu13051514 · Cited by 92
“Lifestyle modifications, focusing on dietary patterns and physical activity, may improve markers of MetS and further reduce the risk of development of NCDs [13].”
BackgroundInfluentialKenđel Jovanović, G., Mrakovcic-Sutic, I., Pavičić Žeželj, S., Šuša, B., Rahelić, D., & Klobučar Majanović, S. (2020) · Nutrients · doi:10.3390/nu12113583 · Cited by 73
“…that moderate weight loss (between 5 and 10% of one’s initial body weight) resulted in a significant reduction in glucose, triglycerides, and total cholesterol and improved insulin sensitivity by between 30 and 60%, which are e ff ects greater than those seen with insulin-sensitizing drugs [66].”
Metadata
- Authors
- Hoyas, I., & Leon-Sanz, M.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2019-08-24
- Volume
- 8
- Issue
- 9
- Pages
- 1301
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2969414360
- Cited by
- 95
- References
- 28
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.